Supplementary Figure 1: Summary of exome sequencing data. | Nature Genetics

Supplementary Figure 1: Summary of exome sequencing data.

From: Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations

Supplementary Figure 1

(a) Exome tumor-normal sample sizes for bladder cancer (BLCA), breast cancer (BRCA), carcinoid (CARC), chronic lymphocytic leukemia (CLLX), colorectal cancer (COLR), diffuse large B cell lymphoma (DLBC), esophageal adenocarcinoma (ESOP), glioblastoma multiforme (GLBM), head and neck cancer (HNSC), kidney clear cell carcinoma (KIRC), acute myeloid leukemia (LAML), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), medulloblastoma (MEDU), melanoma (MELA), multiple myeloma (MUMY), neuroblastoma (NEUB), ovarian cancer (OVAR), prostate cancer (PRAD), rhabdoid tumor (RHAB) and uterine corpus endometrial carcinoma (UCEC). (b) Reference coordinates for mutation impact annotation29 (SnpEff). CDS, coding sequence.

Back to article page